Veracyte (VCYT) Gains from Investment Securities (2012 - 2026)

Veracyte has disclosed Gains from Investment Securities across 15 years of filings, most recently posting $9.4 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $9.4 million, up 579.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 466.52% YoY), and the FY2025 annual result was -$15.3 million, down 1351.64% from the prior year.
• Gains from Investment Securities came in at $9.4 million for Q1 2026 at Veracyte, up from -$29.9 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $14.7 million in Q3 2025 to a low of -$29.9 million in Q4 2025.
• The 5-year median for Gains from Investment Securities is -$30000.0 (2024), against an average of -$414294.1.
• Across the five-year window, Gains from Investment Securities surged 2394.83% in 2022 and slumped 6413.33% in 2025, its largest moves.
• Veracyte's Gains from Investment Securities stood at $3.2 million in 2022, then slumped by 263.51% to -$5.2 million in 2023, then surged by 125.79% to $1.4 million in 2024, then plunged by 2312.86% to -$29.9 million in 2025, then soared by 131.28% to $9.4 million in 2026.
• The last three Gains from Investment Securities figures came in at $9.4 million (Q1 2026), -$29.9 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.